About TransCon CNP TransCon CNP (navepegritide) is an investigational prodrug of C-type natriuretic peptide (CNP) administered once weekly, designed for continuous inhibition of the overactive FGFR3 pathway in achondroplasia by providing continuous exposure of active CNP to receptors on tissues throughout the body
Liaoning Koncepnutra Co., Ltd Liaoning Koncepnutra Co., Ltd
The specific dosing schedule will be determined by your healthcare provider based on your individual needs and response to treatment
Luciferase reporter assays A bicistronic vector pcDNA3 RLuc POLIRES FLuc (empty reporter) (Addgene, 45642) and pcDNA3 RLuc POLIRES FLuc containing human PRKAA1 5UTR upstream of FLuc (5UTR reporter) were transfected into shCtrl and shGDH1 or shYBX1 Huh7 cells using Lipofectamine 2000 (Thermo Fisher)
Generally, when treating a B-12 deficiency, youll get a 1,000-microgram shot every day or two for the first week (2)
In most cases, yeast infections can be effectively treated with topical or oral antifungal medications while continuing GLP-1 therapy